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Edited by Lukas HuberAbstract Neutral sphingomyelinase (N-SMase) elevated nitric
oxide (NO) production without aﬀecting intracellular Ca2+ con-
centration ([Ca2+]i) in endothelial cells in situ on aortic valves,
and induced prominent endothelium-dependent relaxation of
coronary arteries, which was blocked by Nx-monomethyl-L-
arginine, a NO synthase (NOS) inhibitor. N-SMase induced
translocation of endothelial NOS (eNOS) from plasma mem-
brane caveolae to intracellular region, eNOS phosphorylation
on serine 1179, and an increase of ceramide level in endothelial
cells. Membrane-permeable ceramide (C8-ceramide) mimicked
the responses to N-SMase. We propose the involvement of N-
SMase and ceramide in Ca2+-independent eNOS activation
and NO production in endothelial cells in situ, linking to endo-
thelium-dependent vasorelaxation.
 2004 Published by Elsevier B.V. on behalf of the Federation of
European Biochemical Societies.
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Sphingomyelinase (SMase), a key enzyme of sphingolipid
signaling pathway [1], catalyzes hydrolysis of sphingomyelin
to produce intracellular ceramide, which is a lipid second mes-
senger for various cellular actions including cell diﬀerentiation
and proliferation [2]. Various SMases have been found in
mammalian cells, tissues and biological ﬂuids including serum
[1].
Nitric oxide (NO) generated by endothelial NO synthase
(eNOS) plays an important role in regulating vascular tone.
An elevation of intracellular Ca2+ concentrations ([Ca2+]i)
has been believed to be necessary to activate eNOS [3]. How-
ever, recently accumulating reports show that eNOS activity
is also regulated by phosphorylation of the enzyme, cellular
localization, and protein–protein interaction [4]. Although itAbbreviations: SMase, sphingomyelinase; N-SMase, neutral SMase;
NO, nitric oxide; [Ca2+]i, intracellular Ca
2+ concentration; NOS, nitric
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doi:10.1016/j.febslet.2004.11.100is reported that SMase induces endothelium-dependent relaxa-
tion [5], the mechanism of SMase-induced vasorelaxation has
never been elucidated. The aim of this study is to clarify how
SMase induces endothelium-dependent relaxation.
In the present study, we found for the ﬁrst time that in endo-
thelial cells in situ neutral SMase (N-SMase) (E.C. 3.1.4.12)
produces ceramide and induces Ca2+-independent eNOS acti-
vation, probably mediated by translocation of eNOS from
the plasma membrane caveolae to intracellular region and by
phosphorylation on serine 1179 of eNOS.2. Materials and methods
2.1. Materials
SMase from Bacillus cereus, ATP, and U46619 were purchased from
Sigma (USA). Fura-2/AMwas from DOJINDO (Japan). 4,5-Diamino-
ﬂuorescein diacetate (DAF-2/DA) was from Daiichi Chemical (Japan).
Bradykinin (BK) was from Peptide Institute (Japan). Nx-Monom-
ethyl-L-arginine (LNMMA) was from Wako Pure Chemical (Japan).
All other chemicals were from Katayama Chemical (Japan).
2.2. Preparations of the tissue specimens
Bovine aortic valves and coronary arteries (left anterior descending
arteries) were obtained from a local abattoir. The tissue specimens
were placed in ice-cold physiological salt solution (PSS (mM); 123
NaCl, 4.7 KCl, 15.5 NaHCO3, 1.2 KH2PO4, 1.2 MgCl2, 1.25 CaCl2
and 11.5 D-glucose) and transported to our laboratory. All solutions
were gassed with a mixture of 5% CO2 and 95% O2 (pH adjusted to
7.4 at 37 C).
2.3. Force recording of arterial rings with or without endothelium
Tension study was done, as previously described [6,7]. The presence
of endothelium was examined by application of 1 lM BK. Eﬀects of
N-SMase on the force were then examined at the plateau phase of
the sustained contraction induced by 100 nM U46619. In some rings,
the endothelium was removed by rubbing with a cotton web.
2.4. Measurement of [Ca2+]i of the endothelial cells in situ
Monitoring of [Ca2+]i in the endothelial cells in situ was done, as pre-
viously described [6,7]. Brieﬂy, the ﬂuorescence intensities at alternat-
ing 340 nm (F340) and 380 nm (F380) excitation and their ratio
(R = F340/F380) were monitored at 510 nm emission. The ﬂuorescence
ratio values were normalized by the peak response to 10 lM ATP
(=100%).
2.5. Measurement of NO production of the endothelial cells in situ
Nitric oxide production in endothelial cells in situ was measured
with ﬂuorescent indicator DAF-2 [8,9]. Bovine aortic valvular strips
(4 · 3 mm) were loaded with 10 lM DAF-2/DA for 30 min at 37 C
in PSS. Changes in NO production were monitored using diami-
notriazoloﬂuorescein produced from DAF-2 in spectroﬂuorometeration of European Biochemical Societies.
Fig. 1. Representative recordings showing the eﬀects of N-SMase
(0.05 U/ml) and 10 lM C8-ceramide on the contraction of bovine
coronary arteries. BK (1 lM) was applied to examine the endothelium-
dependent relaxation. N-SMase or C8-ceramide was applied after 100
nM U46619-induced contraction reached a steady-state level in the
arteries with (A and C) and without (B and D) endothelium.
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monitored at 515 nm emission. Before starting the experimental proto-
col, all strips were stimulated by 1 lM BK for 5 min in order to obtain
a reference response. The ﬂuorescence values were normalized by the
peak response to 1 lM BK (=100%).
2.6. Immunostaining of endothelial cells in situ
Confocal images of immunocytochemistry of strips of bovine aortic
valves (2 · 3 mm) were observed under a confocal laser scan micro-
scope (LSM510, Zeiss), as described [7]. The ﬁxed and permeabilized
cells were incubated with monoclonal mouse anti-eNOS (Transduction
Laboratories) and rabbit anti-caveolin-1 (Santa Cruz Biotechnology)
antibodies, then incubated with an Alexa546-conjugated anti-mouse
IgG (Molecular Probe) and an Alexa488-conjugated anti-rabbit IgG
(Molecular Probe).
2.7. Measurement of eNOS phosphorylation on serine 1179
To assess eNOS phosphorylation, we performed immunoblot analy-
ses in lysates of endothelial cells of bovine aortic valves, as described
[10]. The strips of valves were immediately frozen with liquid nitrogen,
crushed by using SK mill (Tokken, Japan), and lysed in lysis buﬀer of
50 mM Tris, pH 7.4, 1 mM EDTA, 1% vol/vol NP-40, 150 mM NaCl,
2 mM Na3VO4, 0.25% sodium deoxycholate, 1 mM NaF, 2% SDS,
10% glycerol, 5% 2-mercaptoethanol, 0.008% bromophenol blue, and
1% protease inhibitor cocktail. After centrifugation (14 000 · g, 20
min), the solubilized preparations were subjected to 10% SDS–PAGE
and electroblotted onto PVDF membrane. After blocking, membranes
were incubated with anti-eNOS antibody (Transduction Laboratories)
at 1:1000 dilution or anti-phospho-eNOS Ser1179 antibody (Cell Signal-
ing) at 1:200 dilution at 4 C, overnight, and the antigens were visual-
ized using enhanced chemiluminescence.
2.8. Measurement of ceramide concentration
Bovine aortic valves were preincubated with 50 lM PDMP, a glyco-
syltransferase inhibitor, and 30 lM oleoylethanolamine, a ceramidase
inhibitor, at 37 C for 75 min. After stimulation, endothelial cells of
bovine aortic valves were removed with a razor blade in ice-cold buﬀer
(50 mM Tris–HCl, pH 7.4, 2 mM EGTA, 2 mM EDTA, 1 mM phen-
ylmethylsulfonyl ﬂuoride, 100 lg/ml leupeptin and 10 lg/ml aprotinin)
and collected by centrifugation at 15 000 · g for 5 min at 4 C. Lipids
were extracted from cell homogenates according to the Folch method.
The chloroform phase was dried, dissolved by 100 ll chloroform, and
spotted on thin layer chromatography (TLC) plates (Silica gel 60,
Merck, Germany). Developmental conditions and immunostaining
method were described previously [11]. TLC plates were developed
in a multiple development system. After blocking, the TLC plates were
incubated with an anti-ceramide antibody (Azwell Inc., Japan) at 1:100
dilution, then treated with alkaline phosphatase-conjugated anti-
mouse IgM (Sigma), and stained using a BCIP-NBT Kit (Bio-Rad,
USA). After immunostaining, TLC plates were sprayed with 48%
H2SO4, heated at 170 C for 30 min, then the proportion of ceramide
to total phospholipids was determined on a NIH image.2.9. Statistics
The values are expressed as means ± S.E. Students t test was used to
determine statistical signiﬁcance. P values < 0.05 were considered to be
statistically signiﬁcant.3. Results
3.1. Eﬀects of N-SMase on contraction in bovine coronary
artery
We examined if N-SMase may induce endothelium-depen-
dent vasorelaxation. N-SMase (0.05 U/ml) caused a remark-
able relaxation (61.6 ± 4.96%, n = 19) of bovine coronary
arteries with endothelium precontracted by 100 nM U46619
(Fig. 1A), and a response to 100 nM U46619 was maintained
after washing (data not shown). Although N-SMase (0.1 U/ml)
caused a larger endothelium-dependent relaxation, the re-sponses to 100 nM U46619 reduced after washing (data not
shown). Therefore, we use 0.05 U/ml of N-SMase in our exper-
iments. The relaxations reached the maximum at about 15 min
after application of N-SMase (0.05 U/ml). The N-SMase-in-
duced relaxation was blocked by a NOS inhibitor (3 mM
LNMMA) (Fig. 1A) and the removal of endothelium (Fig.
1B), suggesting that N-SMase induces endothelium-dependent
relaxation presumably by the activation of eNOS. C8-ceramide
(10 lM) induced similar eﬀects (Fig. 1C and D), although the
response was smaller than the N-SMase response.3.2. Eﬀects of N-SMase on [Ca2+]i and NO production in
endothelial cells in situ
Because most of eNOS activations are accompanied with
[Ca2+]i elevation, we examined the in situ eﬀects of N-SMase
(0.05 U/ml) on the [Ca2+]i levels in endothelial cells on bovine
aortic valves. N-SMase induced no apparent changes in
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(n = 5, Fig. 2A).
We then determined if N-SMase may increase NO produc-
tion in endothelial cells in situ. A ﬂuorometrical measurement
of NO production using DAF-2DA showed that N-SMase
(0.05 U/ml) gradually increased NO production (n = 3), the ex-
tent of which was comparable to that of the BK-induced one
(Fig. 2B).Fig. 2. Representative recordings showing changes in [Ca2+]i (A) and
NO production (B). N-SMase was applied 15 min after the stimulation
of 10 lMATP (A) or 1 lM BK (B). Note that initial sharp spike in the
[Ca2+]i measurement is due to the noise of solution change, because
vehicle also induced exactly the same spike.
Fig. 3. Representative confocal images showing the immunostaining of eNOS
in green) and merged view of the both dyes in the presence and absence of 0The [Ca2+]i-independent NO production by N-SMase may
be due to either Ca2+-independent activation of eNOS or sim-
ple activation of iNOS (a Ca2+-independent NOS), which is
sometimes induced in the cultured endothelial cells. However,
in endothelial cells in situ we studied, only eNOS, but not
iNOS, was expressed (data not shown). Taken together, these
ﬁndings suggest that N-SMase activates eNOS (but not iNOS)
without a [Ca2+]i elevation and thereby stimulates NO produc-
tion in endothelial cells in situ.
3.3. Eﬀects of N-SMase on localization of eNOS and caveolin-1
in endothelial cells in situ
The interaction of eNOS with caveolin in plasma membrane
caveolae in endothelial cells is important for the regulation of
its activity [12,13]. Therefore, we next examined if N-SMase
may induce translocation of eNOS in endothelial cells in situ.
At rest, both eNOS and caveolin-1 are colocalized in the plas-
ma membrane (Fig. 3). After treatment of N-SMase (0.05 U/
ml, 15 min), eNOS was translocated from the plasma mem-
brane to intracellular region (especially the perinuclear region),
whereas caveolin-1 remained at the plasma membrane even
after the stimulation (Fig. 3). These results suggest that N-
SMase induces translocation of eNOS from the caveolae to
the intracellular region without a [Ca2+]i elevation in endothe-
lial cells.
3.4. Eﬀects of N-SMase on eNOS phosphorylation on serine
1179 in endothelial cells in situ
Phosphorylation of eNOS on serine 1179 is a major mech-
anism for Ca2+-independent activation of eNOS [14,15].
Therefore, we examined its involvement in eNOS activation
by N-SMase in endothelial cells in situ. N-SMase (0.05 U/
ml, 15 min) signiﬁcantly (P < 0.05) increased phosphorylation
of eNOS on serine 1179 to 179.9 ± 30.4% (n = 5) (Fig. 4A
and B).
3.5. Eﬀects of N-SMase on ceramide level in endothelial cells of
bovine aortic valves
We determined if N-SMase increases ceramide in endothelial
cells in situ of bovine aortic valves. N-SMase (0.05 U/ml, for
15 min) increased remarkably ceramide concentrations(labeled with Alexa 546 in red) and caveolin-1 (labeled with Alexa 488
.05 U/ml N-SMase (for 15 min).
Fig. 5. Changes in ceramide levels. (A) Representative immunostain-
ing on the TLC plate. (B) Statistical evaluation of eﬀects of N-SMase
on the ceramide level, which was expressed as the proportion of
ceramide for total phospholipids and that in control was assigned to
100% (**P < 0.01). The band for C16-ceramide (10 nmol) was also
observed as a reference.
Fig. 4. Changes in phosphorylation levels of eNOS (P-eNOS).
(A) Representative immunoblots using anti-eNOS or anti-eNOS
phopho-Ser 1179 antibodies. (B) Statistical evaluation of eﬀects of
N-SMase (0.05 U/ml for 15min) on the P-eNOS level, which was
expressed as the proportion of P-eNOS for total eNOS and that in
control was assigned to 100% (*P < 0.05).
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ﬁnding strongly suggests that elevation of NO production by
N-SMase may be mediated by an increase of intrinsic ceramide
concentration in endothelial cells in situ.4. Discussion
The present study demonstrates for the ﬁrst time that N-
SMase induces activation of eNOS without elevation of
[Ca2+]i in endothelial cells in situ, and the mechanisms of
eNOS activation by N-SMase involve translocation of eNOS
from the caveolae to the perinuclear region, an increase of
eNOS phosphorylation on serine 1179, and an increase of cer-
amide level in endothelial cells in situ. In addition, the Ca2+-
independent eNOS activation induced by N-SMase causes
prominent endothelium-dependent vasorelaxation.
Two major mechanisms for activation of eNOS in endo-
thelial cells have been proposed: (1) dissociation of eNOS
from caveolin-1, a caveolae-localizing protein that inacti-
vates eNOS; (2) eNOS phosphorylation on serine 1179.
Firstly, proper subcellular localization of eNOS is critical
for activation of eNOS by agonists [16]. In a resting state
of endothelial cells, caveolae-bound eNOS is inactivated by
interaction with caveolin-1, whereas upon receptor activation
the resultant [Ca2+]i elevation stimulates the dissociation of
eNOS from caveolin-1, thereby activating eNOS [17]. This
process has been considered to be a major mechanism for
the Ca2+-dependent activation of eNOS in endothelial cells[18]. However, we previously reported that eicosapentaenoic
acid induces Ca2+-independent activation of eNOS in endo-
thelial cells, which is accompanied with the translocation of
membrane eNOS to the cytosol [7]. In addition, Igarashi et
al. previously demonstrated that C2-ceramide, a membrane
permeable ceramide, stimulates NO production without
[Ca2+]i elevation in cultured endothelial cells, which is
accompanied with the translocation of eNOS from caveo-
lin-bound caveolae [19]. Therefore SMase, which produces
intrinsic ceramide, may also activate eNOS by the same
mechanism. Secondly, eNOS can be activated [Ca2+]i-inde-
pendently by the phosphorylation on serine 1179, through
the activation of Akt [14,15,20]. Although eNOS activation
by VEGF, which increases eNOS phosphorylation on serine
1179, is not accompanied with translocation of eNOS [21],
our study shows that the N-SMase-induced eNOS activation
involves both of translocation of eNOS from the plasma
membrane to the perinuclear region (Fig. 3) and increase
of phosphorylated eNOS on serine 1179 (Fig. 4). TNF-a,
which activates N-SMase, increases ceramide level and acti-
vates eNOS, which is accompanied with phosphorylation of
Akt on serine 473 and of eNOS on serine 1179 in eNOS-Tet
oﬀ cells [22,23]. In the present study, N-SMase increased cer-
amide level in the endothelial cells in situ (Fig. 5). Taken to-
gether, these ﬁndings raise the possibility that ceramide may
activate eNOS not only by stimulating its dissociation from
caveolin-1, but also by increasing eNOS phosphorylation on
serine 1179 probably by Akt, without elevation of [Ca2+]i in
the endothelial cells in situ. Indeed, C8-ceramide showed
similar eﬀects as N-SMase in the experiment of tension
study (Fig. 1C and D).
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N-SMase was accompanied with a marked and sustained vaso-
relaxation (Fig. 1). Zn2+-stimulated SMase has been found in
fetal bovine serum [24]. Although the SMase shows optimal
activity at pH 5.5, its activity at pH 7.4 is about 0.001 U/ml
at optimal condition. If the SMase has the same eﬀects of N-
SMase, the SMase might induce endothelium-dependent vaso-
relaxation. As considering the elevation of ceramide level by a
physiological agonist, BK [19], N-SMase and ceramide may
play a physiological role in the regulation of vascular tone in
an endothelial Ca2+-independent manner. Further studies are
required for the determination of this notion.
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